Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (151-160 of 434) with videos related to

Pageof 44
Sort By:
Oncotarget|April 19, 2017
Identification of long non-coding RNAs that stimulate cell survival in bladder cancerAleksandra M Dudek, Sabrina J Boer, Nanda Boon, et al.
Clinical Chemistry|June 27, 2006
Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrenceIman J Schultz, Lambertus A Kiemeney, Johannes L Willems, et al.
European Urology Focus|May 22, 2018
A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future researchCharlotte T J Michels, Carl J Wijburg, Erik Leijte, et al.
The Journal of Urology|August 22, 2025
Letter: Updates to Microhematuria: AUA/SUFU Guideline (2025)Shahrokh F Shariat, Bas W G van Rhijn, Christian Bolenz, et al.
The American Journal of Clinical Nutrition|February 13, 2023
Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrenceMoniek van Zutphen, Jasper P Hof, Katja Kh Aben, et al.
European Urology Oncology|November 23, 2023
Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective CohortIvy Beeren, Nena E Klerks, Katja K Aben, et al.
Cancer Medicine|June 2, 2018
LINC00857 expression predicts and mediates the response to platinum-based chemotherapy in muscle-invasive bladder cancerAleksandra M Dudek, Jasmijn G M van Kampen, J Alfred Witjes, et al.
European Urology|March 24, 2004
Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapyBarthold Ph Schrier, Maarten P Hollander, Bas W G van Rhijn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trialRianne J M Lammers, Wim P J Witjes, Maria H D Janzing-Pastors, et al.
Urologic Oncology|July 16, 2014
The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancerAnne J Grotenhuis, Cornelis W Ebben, Katja K Aben, et al.
Pageof 44

Showing results (151-160 of 434) with videos related to

Sort By:
Pageof 44
Oncotarget|April 19, 2017
Identification of long non-coding RNAs that stimulate cell survival in bladder cancerAleksandra M Dudek, Sabrina J Boer, Nanda Boon, et al.
Clinical Chemistry|June 27, 2006
Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrenceIman J Schultz, Lambertus A Kiemeney, Johannes L Willems, et al.
European Urology Focus|May 22, 2018
A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future researchCharlotte T J Michels, Carl J Wijburg, Erik Leijte, et al.
The Journal of Urology|August 22, 2025
Letter: Updates to Microhematuria: AUA/SUFU Guideline (2025)Shahrokh F Shariat, Bas W G van Rhijn, Christian Bolenz, et al.
The American Journal of Clinical Nutrition|February 13, 2023
Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrenceMoniek van Zutphen, Jasper P Hof, Katja Kh Aben, et al.
European Urology Oncology|November 23, 2023
Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective CohortIvy Beeren, Nena E Klerks, Katja K Aben, et al.
Cancer Medicine|June 2, 2018
LINC00857 expression predicts and mediates the response to platinum-based chemotherapy in muscle-invasive bladder cancerAleksandra M Dudek, Jasmijn G M van Kampen, J Alfred Witjes, et al.
European Urology|March 24, 2004
Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapyBarthold Ph Schrier, Maarten P Hollander, Bas W G van Rhijn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trialRianne J M Lammers, Wim P J Witjes, Maria H D Janzing-Pastors, et al.
Urologic Oncology|July 16, 2014
The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancerAnne J Grotenhuis, Cornelis W Ebben, Katja K Aben, et al.
Pageof 44